B. Gerber
- Cancer Research top 1%
- Breast Cancer Treatment Studies 52
- Oncology top 2%
- Cancer Treatment and Pharmacology 30
- HER2/EGFR in Cancer Research 19
- Equine top 2%
- Small Animals top 1%
- Veterinary Medicine and Surgery 15
-
- Breast Lesions and Carcinomas 15
-
- Advanced Breast Cancer Therapies 21
-
- Venous Thromboembolism Diagnosis and Management 14
-
- Ovarian cancer diagnosis and treatment 12
- Co-authors
- Toralf ReimerClaudia E ReuschSibylle LoiblHolger EidtmannGϋnter von MinckwitzChristian JackischJ. HilfrichK. Mehta
- Cited by
- Cancer ResearchOncologyEquine
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Research (15 papers)Annals of Oncology (9 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
B. Gerber
212 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 1.3k
- Oncology 1.4k
- Equine 84
- Small Animals 362
- Pathology and Forensic Medicine 613
Countries citing papers authored by B. Gerber
This map shows the geographic impact of B. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gerber more than expected).
Fields of papers citing papers by B. Gerber
This network shows the impact of papers produced by B. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gerber. The network helps show where B. Gerber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Gerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 5 | |
| 5 | 2020 | 69 | |
| 6 | 2019 | 12 | |
| 7 | 2018 | 39 | |
| 8 | 2018 | 1 | |
| 9 | 2017 | 98 | |
| 10 | 2016 | 10 | |
| 11 | 2016 | 16 | |
| 12 | 2015 | 21 | |
| 13 | 2013 | 14 | |
| 14 | 2013 | 172 | |
| 15 | 2012 | 43 | |
| 16 | 2012 | 10 | |
| 17 | 2011 | 74 | |
| 18 | 2005 | 13 | |
| 19 | 1999 | 9 | |
| 20 | 1999 | 3 |
About B. Gerber
B. Gerber is a scholar working on Cancer Research, Internal Medicine and Oncology, having authored 232 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (52 papers), Cancer Treatment and Pharmacology (30 papers), Advanced Breast Cancer Therapies (21 papers), HER2/EGFR in Cancer Research (19 papers), Breast Lesions and Carcinomas (15 papers), Veterinary Medicine and Surgery (15 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Ovarian cancer diagnosis and treatment (12 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.4k citations) and Equine (84 citations). B. Gerber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Toralf Reimer, Claudia E Reusch, Sibylle Loibl, Holger Eidtmann, Gϋnter von Minckwitz, Christian Jackisch, J. Hilfrich, K. Mehta, Jens Huober and Jens‐Uwe Blohmer. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Journal of Veterinary Internal Medicine and Swiss Medical Weekly.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.